141 related articles for article (PubMed ID: 27214145)
1. Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator AZD5423 after Inhalation in Healthy Volunteers.
Werkström V; Prothon S; Ekholm E; Jorup C; Edsbäcker S
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):574-581. PubMed ID: 27214145
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Tolerability of an Inhaled Selective Glucocorticoid Receptor Modulator - AZD5423 - in Chronic Obstructive Pulmonary Disease Patients: Phase II Study Results.
Kuna P; Aurivillius M; Jorup C; Prothon S; Taib Z; Edsbäcker S
Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):279-289. PubMed ID: 28212463
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of the Inhaled Selective Glucocorticoid Receptor Modulator AZD5423 Following Inhalation Using Different Devices.
Melin J; Prothon S; Kloft C; Cleton A; Amilon C; Jorup C; Bäckman P; Olsson B; Hamrén UW
AAPS J; 2017 May; 19(3):865-874. PubMed ID: 28281196
[TBL] [Abstract][Full Text] [Related]
4. Predicting Exposure After Oral Inhalation of the Selective Glucocorticoid Receptor Modulator, AZD5423, Based on Dose, Deposition Pattern, and Mechanistic Modeling of Pulmonary Disposition.
Bäckman P; Tehler U; Olsson B
J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):108-117. PubMed ID: 27740878
[TBL] [Abstract][Full Text] [Related]
5. Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator Velsecorat (AZD7594) Following Inhalation in Healthy Volunteers.
Prothon S; Aurivillius M; Tehler U; Eriksson UG; Aggarwal A; Chen Y
Drug Des Devel Ther; 2022; 16():485-497. PubMed ID: 35264846
[TBL] [Abstract][Full Text] [Related]
6. Safety, pharmacokinetics and pharmacodynamics of the selective glucocorticoid receptor modulator AZD7594, following inhalation in healthy Japanese volunteers.
Prothon S; Wählby Hamrén U; Tehler U; Yoon E; Forsman H; Arfvidsson C; Aggarwal A; Chen Y
Drug Des Devel Ther; 2019; 13():3845-3853. PubMed ID: 31814707
[TBL] [Abstract][Full Text] [Related]
7. Influence of high dose inhaled steroids on hypothalamo-pituitary-adrenal axis function in Japanese patients with asthma: a comparison over the course of time.
Hasegawa T; Ishihara K; Fujii H; Hajiro T; Watanabe I; Nishimura T; Okazaki M; Katakami N; Umeda B
Intern Med; 1996 May; 35(5):362-6. PubMed ID: 8797047
[TBL] [Abstract][Full Text] [Related]
8. Inhaled beclomethasone dipropionate suppresses the hypothalamo-pituitary-adrenal axis in a dose dependent manner.
Grebe SK; Feek CM; Durham JA; Kljakovic M; Cooke RR
Clin Endocrinol (Oxf); 1997 Sep; 47(3):297-304. PubMed ID: 9373450
[TBL] [Abstract][Full Text] [Related]
9. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of QMF149 in Japanese versus Caucasian subjects: an open-label, randomized phase I study.
Shimada S; Vaidya S; Khindri S; Tashiro N; Cheng Y; Hara H; Majumdar T; Woessner R; Furihata K; Kobayashi K
Int J Clin Pharmacol Ther; 2015 May; 53(5):398-407. PubMed ID: 25740265
[TBL] [Abstract][Full Text] [Related]
11. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma.
Scott MB; Skoner DP
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):200-9. PubMed ID: 10518847
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, Safety, and Tolerability of a New Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate Diskus(®) in Healthy Adults.
Vutikullird AB; Gillespie M; Song S; Steinfeld J
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):207-14. PubMed ID: 26624976
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteers.
Poli G; Acerbi D
Respir Med; 2003 Feb; 97 Suppl B():S5-9. PubMed ID: 12593521
[TBL] [Abstract][Full Text] [Related]
14. Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study.
Allen A; Schenkenberger I; Trivedi R; Cole J; Hicks W; Gul N; Jacques L
Clin Respir J; 2013 Oct; 7(4):397-406. PubMed ID: 23578031
[TBL] [Abstract][Full Text] [Related]
15. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.
Goldberg S; Einot T; Algur N; Schwartz S; Greenberg AC; Picard E; Virgilis D; Kerem E
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):566-71. PubMed ID: 12487221
[TBL] [Abstract][Full Text] [Related]
16. Fluticasone propionate in children with moderate asthma.
Hoekstra MO; Grol MH; Bouman K; Stijnen T; Köeter GH; Kauffman HF; Gerritsen J
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1039-44. PubMed ID: 8887604
[TBL] [Abstract][Full Text] [Related]
17. Evidence of hypothalamic-pituitary-adrenal axis suppression during moderate-to-high-dose inhaled corticosteroid use.
Cavkaytar O; Vuralli D; Arik Yilmaz E; Buyuktiryaki B; Soyer O; Sahiner UM; Kandemir N; Sekerel BE
Eur J Pediatr; 2015 Nov; 174(11):1421-31. PubMed ID: 26255048
[TBL] [Abstract][Full Text] [Related]
18. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR
Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
[TBL] [Abstract][Full Text] [Related]
19. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze.
Cetinkaya F; Kayiran P; Memioglu N; Tarim OF; Eren N; Erdem E
Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460
[TBL] [Abstract][Full Text] [Related]
20. Inhaled corticosteroids: Ocular safety and the hypothalamic-pituitary-adrenal axis.
Carr WW; Szefler SJ
Ann Allergy Asthma Immunol; 2016 Dec; 117(6):589-594. PubMed ID: 27979014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
